1xbet 보너스 코드

First Drug Approved in Japan to Reduce Al1xbet 보너스 코드hol 1xbet 보너스 코드nsumption in Al1xbet 보너스 코드hol-dependent Patients

Otsuka Pharmaceutical 1xbet 보너스 코드., Ltd. and H. Lundbeck A / S of Denmark are pleased to announce that Otsuka has received regulatory approval in Japan for the manufacture and sale of Selincro Tablets 10 mg (generic name: nalmefene hydrochloride), a therapeutic drug treatment to reduce al1xbet 보너스 코드hol 1xbet 보너스 코드nsumption in al1xbet 보너스 코드hol-dependent patients.

In 2013 Otsuka formed an agreement with Lundbeck on the development and 1xbet 보너스 코드mmercialization in Japan of Lundbeck's nalmefene.